U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291557) titled 'PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer' on Nov. 25.
Brief Summary: In this study, prostate cancer patients whose cancer has not spread to the lymph nodes will receive radiation therapy targeted to the prostate and nearby tissues with or without whole pelvis radiation therapy. PSMA imaging will be used to visualize prostate cancer prior to starting the trial.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
RADIATION: Prostate Only Radiation Therapy (PORT)
6800cGy in 25 daily fractions to the prostate and surrounding tissues
RADIATION: Prostate + Whole ...